STROKE - Liaquat University of Medical & Health Sciences
Download
Report
Transcript STROKE - Liaquat University of Medical & Health Sciences
STROKE
By
Dr. Bikha Ram Devrajani
FCPS, FACP, FRCP
Professor Medicine
Liaquat University of Medical & Health
Sciences, Jamshoro
BIKHA
Definition of Stroke
Acute focal neurological deficit resulting
from cerebrovascular disease and lasting
more than 24-hours (or causing earlier
death)
BIKHA
Definition of Stroke
Stroke is not a diagnosis but a clinical
syndrome with numerous causes
The main types of stroke and their relative
occurrence are:
Cerebral infarction (85%)
Intracerebral haemorrhage (10%)
Subarachnoid haemorrhage (5%)
BIKHA
Transient Ischaemic Attack (TIA)
Also defined as an acute focal neurological
deficit resulting from cerebrovascular
disease, but the symptoms and signs
resolve within 24-hours
Most patients recover within 30-min
No fundamental difference between TIA and
stroke except for the duration of the
symptoms
BIKHA
Epidemiology of Stroke
Stroke is the third leading cause of death in
the United States and a leading cause of
serious, long-term disability.
In the United States there is one stroke
patient in every 45 seconds.
BIKHA
Haemorrhagic
15%
Ischaemic
85%
BIKHA
Thromboembolism
Heart
25%
Large Vessels and
others
50%
Small Vessel Disease
25%
BIKHA
BIKHA
Pathophysiology
Clinical Classification of Focal Stroke.
Transient if the deficit recover within 24 h.
Completed if the focal deficit is persistent.
Evolving if focal deficit continues to worsen
after about 6 h from onset.
BIKHA
Pathophysiology
Cerebral Infarction
Infarction is a process which takes some
hours to complete.
BIKHA
Pathophysiology
Cerebral Infarction
a. Occlusion of a cerebral artery, the opening
of anastomatic channels from other arterial
territories may restore perfusion.
b. Reduction in perfusion pressure leads to
homeostatic changes to maintain
oxygenation of brain vasodilation of
cerebral artery.
BIKHA
Cerebral Infarction
Pathophysiology
c. If homeostatic process fails ischaemia
begins - ultimately leads to infarction.
i. When the blood-flow falls below threshold for
maintenance of electrical activity neurological
deficit appears – but neurons are still viable.
At this stage if blood-flow restores then
recovery will be definite (TIA).
ii. If flow further falls, then cell death process
starts.
BIKHA
Pathophysiology
BIKHA
Pathophysiology
Cerebral Infarction
Final result of occlusion of a cerebral blood
vessel depends upon:
i. Competence of the circulatory homeostatic
mechanism.
ii. Severity of reduction of blood-flow.
iii. Duration of reduction of blood-flow.
BIKHA
Pathophysiology
BIKHA
Pathophysiology
Cerebral Infarction
If ischaemic damage is affecting the
endothelium of vessel then there is chance
of haemorrhage in the infarction by blood’s
thrombolytic mechanism.
BIKHA
Pathophysiology
Cerebral Infarction
Radiologically infarct can be seen as a
lesion which is composed of:
• Ischaemic.
• Swollen but recoverable (pnemubra).
• Finally infarcted area will be replaced fluid
filled cavity (liquification necrosis).
BIKHA
Ischaemia
Energy Failure
Depolarization
Glutamate Release
Na+/Ca++ Influx
Cellular Swelling
Free Radical Generation
Mitochondrial Injury
Necrotic Cell Death
Enzyme Activity
BIKHA
BIKHA
BIKHA
BIKHA
Pathophysiology
Intracerebral Haemorrhage
Cessation of functions of affected parts.
As neurons are structurally distrupted and
white matter fibre tract split apart.
Rim of cerebral oedema around
haemorrhage.
BIKHA
Pathophysiology
Intracerebral Haemorrhage
If big haemorrhage the shifting of midline
and transtentorial causing rapid death.
If survives then haemosidrin lined slit in
brain parenchyma.
BIKHA
CT Scan of Intracerebral Haemorrhage
BIKHA
Causes of Cerebral Infarction
(75-80% of all strokes)
Large artery atherothromboembolism =50%
• Extracranial (aorta, carotid, vertebral arteries)
= 40-45%
• Intracranial (ICA, MCA, ACA, vertebral, basilar,
PCA) = 5-10%
Small artery diseases
(microatheroma/lipohyalinosis) = 20-25%
BIKHA
BIKHA
Causes of Cerebral Infarction
(75-80% of all strokes)
Large artery atherothromboembolism =50%
• Extracranial (aorta, carotid, vertebral arteries)
= 40-45%
• Intracranial (ICA, MCA, ACA, vertebral, basilar,
PCA) = 5-10%
Small artery diseases
(microatheroma/lipohyalinosis) = 20-25%
BIKHA
Causes of Cerebral Infarction
(75-80% of all strokes) Contd:
Embolism from the heart = 20%
Non-atheromatous arterial disease (e.g.
dissection, arteritis) = 5%
Blood disease (thrombophilia) <5%
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence)
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence)
Right to left shunt (paradoxical emboli
from the venous system) via:
Patent foramen ovale
Atrial septal defect
Ventricular septal defect
Pulmonary arteriovenous malformation
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd.
Left Atrium
Thrombus:
• atrial fibrillation*
• sinoatrial disease (sick sinus syndrome)
• atrial septal aneurysm
Myxoma and other tumours*
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd:
Mitral Valve
Rheumatic endocarditis (stenosis* or
regurgitation)
infective endocarditis*
Mitral annulus calcification
Mitral valve prolapse
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd:
Mitral Valve
Non-bacterial thrombotic (marantic)
endocarditis.
Libman-Sacks endocarditis
Prosthetic heart valve*
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd:
Left Ventricle
Mural thrombus:
• acute myocardial infarction (within previous
few weeks)*
• left ventricular aneurysm or akinetic
segment
• dilated cardiomyopathy*
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd:
Left Ventricle
Mural thrombus:
• mechanical ‘artificial’ heart*
• blunt chest injury (myocardial contusion)
Myxoma and other tumours*
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd:
Aortic Valve
Rheumatic endocarditis (stenosis or
regurgitation).
Infective endocarditis*
Syphilis
Non-infective thrombotic (marantic)
endocarditis
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd:
Aortic Valve
Libman-Sacks endocarditis
Prosthetic heart valve*
Calcific stenosis/sclerosis/calcification
* substantial risk of embolism
BIKHA
Cardiac Sources of Embolism
(in anatomical sequence) Contd.
Congenital heart disease (particularly with
right to left shunt)
Cardiac manipulation/ surgery/
catheterisation/ valvuloplasty/ angioplasty
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
‘Complex’ disease (fibrinoid necrosis) in
small, penetrating vessels:
• most common cause in middle and old age
hypertensives
• haemorrhages often deep in putamen (40%),
caudate nucleus (85%), thalamus (15%),
cerebral hemispheres (lobar) (20%),
cerebellum (8%), and brainstem (8%)
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
Amyloid (congophilic) angiopathy*
• most common cause in old age
• haemorrhages often in lobes of cerebral
hemispheres
• may be associated with dementia
* causes of multiple haemorrhages in the brain parenchyma
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
Vascular malformations (arteriovenous
and cavernous angiomas)
• dural or brain
• most common cause of ICH in young
normotensive people
• seizures and headaches commonly antedate
haemorrhage
• cavernous angiomas tend to be multiple and
familial
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
Caroticocavernous fistula
Hereditary haemorrhagic telangiectasia
Saccular aneurysms
• cause 1 in 13 intracerebral haemorrhages (2
in 13 <65 years old), usually in conjunction
with subarachnoid haemorrhage
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
Atheromatous aneurysm
Septic arteritis and mycotic aneurysms
Necrotising angitis of the CNS*
Arterial dissection
* causes of multiple haemorrhages in the brain parenchyma
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
Intracerebral tumours
• primary (glioblastoma, oligodendroglioma,
medulloblastoma, haemangioblastoma)
• metastases (melanoma, bronchial
carcinoma, renal carcinoma,
choriocarcinoma, endometrial carcinoma)
Intracranial venous thrombosis*
* causes of multiple haemorrhages in the brain parenchyma
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
A. Arterial Disease (anatomical factors)
Moyamoya syndrome
Occult head injury*
Trauma
Haemorrhagic brain infarction
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
B. Raised Blood Pressure (haemodynamic
factors)
Acute arterial hypertension
Alcohol (also antiplatelet action, and
coexistent liver disease)
Amphetamines (may also cause a
vasculitis)
Cocaine and other sympathomimetic drugs
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
B. Raised Blood Pressure (haemodynamic
factors)
Monoamine oxidase A inhibitors
Exposure to extreme cold
Trigeminal nerve stimulation
Post carotic endarterectomy, heart
transplantation, or correction of
congenital heart lesions
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
B. Raised Blood Pressure (haemodynamic
factors)
Chronic arterial hypertension, causing
complex small vessel disease (see above)
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
C. Bleeding Diathesis (haemostatic
factors)*
Anticoagulants
• risk of intracerebral haemorrhage is about
1% per year
• Increased risk if elderly, previous stroke,
hypertensive, small vessel disease, and if
INR > 4.0
* causes of multiple haemorrhages in the brain parenchyma
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
C. Bleeding Diathesis (haemostatic
factors)*
Antiplatelet drugs: probably a relatively
minor contributory factor
Thrombolytic treatment
• 0.75% of patients with myocardial infarction
(>2% risk if elderly >65 years, low body
weight <70-kg, hypertensive, and given
alteplase as opposed to streptokinase; 0.3%
risk if none of these risk factors)
* causes of multiple haemorrhages in the brain parenchyma
BIKHA
Causes of Intracerebral
Haemorrhage (10-15% of all strokes)
C. Bleeding Diathesis (haemostatic
factors)*
Thrombocytopenia
Haemophilia & other hereditary
coagulation factor deficiencies (e.g. factor V)
Leukaemia
Diffuse intravascular coagulation
* causes of multiple haemorrhages in the brain parenchyma
BIKHA
Risk Factors for Cerebral Infarction
R e la tiv e
R is k
E s tim a te d a g e s ta n d a rd is e d p re v a le n c e
o f e x p o s u re in
p o p u la tio n (% )
2 -4
2 -4
2
6
1 -3
3 -1 5
7
30
25
3
1
20
4
2
1 -4
3
D e fin ite
in c re a s in g a g e
m a le g e n d e r
in c re a s in g B P
c ig a re tte s m o k in g
d ia b e te s m e llitu s
a tria l fib rilla tio n
is c h a e m ic h e a rt d is e a s e (IH D )
c a ro tid b ru it/s te n o s is
tra n s ie n t is c h a e m ic a tta c k o r
p re v io u s s tro k e
p e rip h e ra l v a s c u la r d is e a s e
(in te rm itte n t c la u d ic a tio n )
in c re a s in g p la s m a fib rin o g en
BIKHA
Risk Factors for Cerebral Infarction
Possible
hyperlipidaemia* (definite for IHD)
hyperhomocystinaemia
activation of the renin-angiotensinaldosterone system
high plasma factor VII coagulant activity
low blood fibrinolytic activity
raised haematocrit
* probable weak (or under-researched) positive association with
ischaemic stroke, and possible weak inverse/negative association
with haemorrhagic stroke
BIKHA
Risk Factors for Cerebral Infarction
Possible
raised von-Willebrand factor antigen
raised tissue plasminogen activity antigen
plasma viscosity (largely determined by
plasma fibrinogen)
physical inactivity
obesity
snoring and sleep apnoea
* probable weak (or under-researched) positive association with
ischaemic stroke, and possible weak inverse/negative association
with haemorrhagic stroke
BIKHA
Risk Factors for Cerebral Infarction
Possible
recent infection
family history of stroke
diet (salt, fat)
alcohol (none, or heavy drinking)
race
social deprivation
stress
* probable weak (or under-researched) positive association with
ischaemic stroke, and possible weak inverse/negative association
with haemorrhagic stroke
BIKHA
Infarction
BIKHA
Infarction
BIKHA
Haemorrhage
BIKHA
Focal Neurological and Ocular
Symptoms
Motor Symptoms
weakness or clumsiness of one side of
the body, in whole or in part (hemiparesis)
simultaneous bilateral weakness
(paraparesis, quadriparesis)*
difficulty swallowing (dysphagia)*
imbalance (ataxia)*
* as an isolated symptom, this does not necessarily indicate focal
brain ischaemia or haemorrhage because there are many other
potential causes
BIKHA
Focal Neurological and Ocular
Symptoms
Speech/Language Disturbances
difficulty understanding or expressing
spoken language (dysphasia)
difficulty reading (dyslexia) or writing
(dysgraphia)
difficulty calculating (dyscalculia)
slurred speech (dysarthria)*
* as an isolated symptom, this does not necessarily indicate focal
brain ischaemia or haemorrhage because there are many other
potential causes
BIKHA
Focal Neurological and Ocular
Symptoms
Sensory Symptoms
Somatosensory
• altered feeling on one side of the body, in
whole or in part (hemisensory disturbance)
* as an isolated symptom, this does not necessarily indicate focal
brain ischaemia or haemorrhage because there are many other
potential causes
BIKHA
Focal Neurological and Ocular
Symptoms
Sensory Symptoms
Visual
• loss of vision in one eye, in whole or in part
(monocular blindness)
• loss of vision in the left or the right half or
quarter of the visual field (hemianopia,
quadrantanopia)
• bilateral blindness
• double vision (diplopia)*
* as an isolated symptom, this does not necessarily indicate focal
brain ischaemia or haemorrhage because there are many other
potential causes
BIKHA
Focal Neurological and Ocular
Symptoms
Vestibular Symptoms
a spinning sensation (vertigo)*
Behavioural/Cognitive Symptoms
difficulty dressing, combing hair, cleaning
teeth etc.; geographical disorientation;
difficulty copying diagrams such as a
clock, flower, or intersecting cubes
(visual-spatial-perceptual dysfunction)
forgetfulness (amnesia)*
* as an isolated symptom, this does not necessarily indicate focal
brain ischaemia or haemorrhage because there are many other
potential causes
BIKHA
Non-focal Neurological Symptoms
Generalised weakness and/or sensory
disturbance
‘Blackouts’ with altered or loss of
consciousness or fainting, with or without
impaired vision in both eyes
Incontinence of urine or faeces
Confusion
BIKHA
Non-focal Neurological Symptoms
Any of the following symptoms, if
isolated:*
A spinning sensation (vertigo)
Ringing in ears (tinnitus)
Difficulty swallowing (dysphagia)
Slurred speech (dysarthria)
Double vision (diplopia)
Loss of balance (ataxia)
* If these symptoms occur in combination, or with focal neurological
symptoms, they may indicate focal cerebral ischaemia
BIKHA
DIFFERENTIAL DIAGNOSIS OF
ISCHEMIC STROKE & TIA
Clinical diagnosis of ischemic or
hemorrhagic stroke depends upon
clinicians understanding of brain function
and pathology.
Deficit that evolve over weeks are usually
caused by:
• Brain mass either primary or metastatic
brain tumor.
• Brain abscess.
• Sub-dural hematoma.
BIKHA
DIFFERENTIAL DIAGNOSIS OF
ISCHEMIC STROKE & TIA
TIA may be confused with classic or
complicated:
• Migraine.
• Seizures.
BIKHA
DIFFERENTIAL DIAGNOSIS OF
ISCHEMIC STROKE & TIA
Hemorrhagic stroke often enters in
differential diagnosis:
• Ischemic strokes.
• Verterobasillary ischemia.
• Non-specific dizziness.
• Meinier’s disease.
• Peripheral vestibulopathy.
BIKHA
Differential Diagnosis of Stroke (in order of
frequency of occurrence in general practice)
Metabolic/toxic encephalopathy
(hypoglycaemia, non-ketotic
hyperglycaemia, hyponatraemia,
Wernicke-Korsakoff syndrome, hepatic
encephalopathy, alcohol and drug
intoxication)
Functional/non-neurological (e.g. hysteria)
Epileptic seizure (postictal Todd’s
paresis) or non-convulsive seizures
BIKHA
Elements of Patient Management
within a Specialist Stroke Unit
Standardised (protocol driven)
investigation and management
Risk assessment for swallowing
Active treatment of contributory factors
Early rehabilitation
Multidisciplinary team
Rationalise medication
Research opportunities
Discharge planning
BIKHA
Tips on Triples in Acute Stroke:
Some Points Worth Remembering
3 h window for safe and effective
thrombolysis
Avoid thrombolyis if infarction already
affects more than 1/3 of MCA territory
Control blood sugar tightly for 3 days
Start blood pressure treatment after 3
days
Take decision on tube feeding at 3 days
BIKHA
Tips on Triples in Acute Stroke:
Some Points Worth Remembering
Three complications to avoid: aspiration,
venous thrombosis, infection
Three groups of patients
(atherothrombotic, cardioembolic and
haemorrhagic) get three different
treatment: aspirin, warfarin or neither
Delay warfarin for 3 weeks after
significant embolic infarct
BIKHA
The 7 D’s of Stroke Care
Detection:
Dispatch
Delivery
Door
Data
Decision
Drugs
BIKHA
Algorithm for Suspected Stroke:
Goals for Management of Stroke
Identify signs of possible stroke
Critical EMS assessments and actions :
Support ABCs; give oxygen if needed
Perform prehospital stroke assessment
Establish time when patient last known normal (Note: therapies may
be available beyond 3 hours from onset)
Transport; consider triage to a center with a stroke unit if
appropriate; consider bringing a witness, family member or
caregiver
Alert hospital
Check glucose if possible
ContinuedBIKHA
Immediate general assessment and stabilization:
Assess ABCs, vital signs
Provide oxygen if hypoxemic
Obtain IV access and blood samples
Check glucose; treat if indicated
Perform neurologic screening assessment
Activate stroke team
Order emergent CT scan of brain
Obtain 12-lead ECG
Immediate neurologic assessment by stroke team or designee
Review patient history
Establish symptom onset
Perform neurologic examination (NIH Stroke Scale or Canadian
Neurologic scale)
ContinuedBIKHA
Does CT scan show any hemorrhage?
No Hemorrhage
Hemorrhage
Probable acute ischemic stroke; consider
Consult neurologist or neurosurgeon;
fibrinolytic therapy:
consider transfer if not available
Check for fibrinolytic exclusions
Repeat neurologic exam: are deficits
rapidly improving to normal
Not a Candidate
Administer aspirin
Patient remains candidate
for fibrinolytic therapy
Candidate
Begin stroke pathway
Review risks / benefits with patient and family: If
Admit to stroke unit if available
acceptable
Monitor BP; treat if indicated
Give tPA
Monitor neurologic status; emergent CT if deterioration
No anticoagulants or antiplatelet treatment for
24 hours
Monitor blood glucose; treat if needed
Initiate supportive therapy; treat comorbidities
BIKHA
Critical Time Periods
Immediate general assessment
10 minutes
Immediate neurologic assessment
25 minutes
Acquisition of head CT
25 minutes
Interpretation of the CT Scan
45 minutes
Administration of fibrinolytics, timed from
ED arrival
60 minutes
Administration of fibrinolytics, timed from
onset of symptoms
3 hours
Admission to a monitored bed
3 hours
BIKHA
BIKHA